Update cognition of nonalcoholic fatty liver disease/metabolism-associated fatty liver disease
- PMID: 35620163
- PMCID: PMC9128561
- DOI: 10.1002/cdt3.14
Update cognition of nonalcoholic fatty liver disease/metabolism-associated fatty liver disease
Keywords: metabolism associated fatty liver disease; nonalcoholic fatty liver disease.
Conflict of interest statement
The authors declare no conflict of interest. Professor Yiming Mu is a member of Chronic Diseases and Translational Medicine editorial board and is not involved in the peer review process of this article.
Similar articles
-
Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.Nutr Hosp. 2017 Jun 5;34(3):727-730. doi: 10.20960/nh.723. Nutr Hosp. 2017. PMID: 28627213 Review.
-
Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease.Microcirculation. 2020 Apr;27(3):e12603. doi: 10.1111/micc.12603. Epub 2020 Jan 14. Microcirculation. 2020. PMID: 31876010
-
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.Clin Liver Dis. 2018 Feb;22(1):23-37. doi: 10.1016/j.cld.2017.08.007. Epub 2017 Oct 18. Clin Liver Dis. 2018. PMID: 29128059 Review.
-
Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease.Front Cell Infect Microbiol. 2021 Oct 28;11:683743. doi: 10.3389/fcimb.2021.683743. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34778099 Free PMC article.
-
PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.World J Gastroenterol. 2015 Jan 21;21(3):794-802. doi: 10.3748/wjg.v21.i3.794. World J Gastroenterol. 2015. PMID: 25624712 Free PMC article. Review.
Cited by
-
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease.J Pers Med. 2023 May 14;13(5):830. doi: 10.3390/jpm13050830. J Pers Med. 2023. PMID: 37241000 Free PMC article. Review.
References
-
- Hardy T, Oakley F, Anstee QM, Day CP. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu Rev Pathol. 2016;11(1):451‐496. - PubMed
-
- Kim GA, Lee HC, Choe J, et al. Association between non‐alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2017;S0168‐8278(17):32294‐32298. - PubMed
-
- Yki‐Järvinen H. Non‐alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2(11):901‐910. - PubMed
-
- Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction‐associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202‐209. - PubMed
-
- Krawczyk M, Liebe R, Lammert F. Toward genetic prediction of nonalcoholic fatty liver disease trajectories: PNPLA3 and beyond. Gastroenterology. 2020;158:1865‐1880. - PubMed
Publication types
LinkOut - more resources
Full Text Sources